Atlas Antibodies AB

Atlas Antibodies acquires HistoCyte Laboratories, a global leader in cell line controls for histopathology

Tue, Feb 16, 2021 16:40 CET

Atlas Antibodies AB has signed an agreement to acquire UK company HistoCyte Laboratories Ltd. HistoCyte Laboratories’ portfolio of innovative cell line materials provides control of immunohistochemical assays used in the diagnosis of cancers. These materials have uniquely tissue-like properties that enhance the quality of tissue-based assays. Formed in 2014, HistoCyte Laboratories has established a significant presence in important markets such as the UK and USA. The company has a strong growth trajectory that is expected to accelerate as acceptance of cell line controls increases

Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins using Mass Spectrometry

Mon, Sep 16, 2019 09:17 CET

STOCKHOLM, Sweden, September 15, 2019. Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography (LC)–mass spectrometry (MS). QPrESTs consists of 50-150 amino acids identical to a part of the corresponding human protein. They are produced recombinantly in the presence of stable isotope-labeled (i.e. heavy) amino acids to generate protein standards. Targeted proteomics is a method

Share

Atlas Antibodies acquires HistoCyte Laboratories, a global leader in cell line controls for histopathology

Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins using Mass Spectrometry

Media